API Goserelin CAS 65807-02-5

Short Description:

Goserelin is used in men to treat prostate cancer. It is used in women to treat certain breast cancers or a certain uterus disorder (endometriosis). It is also used in women to thin the lining of the uterus (endometrium) in preparation for a procedure to treat abnormal uterine bleeding.

Contact: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

WhatsApp: +86 186 2503 6043 (WeChat & Telegram & Line)

Skype: slhyzy

Send email to us

Product Detail

Product Tags

Description

Specification

Product Name	Goserelin
Chemical Name	PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ACETATE SALT
Other Name	GOSERELINACETATESALT;(D-SER(TBU)6,AZAGLY10)-GONADOTROPIN-RELEASINGHORMONEACETATESALT;(D-SER(TBU)6,AZAGLY10)-LHRHACETATESALT;(D-SER(TBU)6,AZAGLY10)-LUTEINIZINGHORMONE-RELEASINGFACTORACChemicalbookETATESALT;(D-SER(TBU)6,AZAGLY10)-LUTEINIZINGHORMONE-RELEASINGHORMONEACETATESALT;2-(aminocarbonyl)hydrazide;decapeptidei
CAS Number	65807-02-5
Molecular Formula	C59H84N18O14
Formula Weight	1269.41
Appearance	White powder
Assay	99.0% min
Density	1.50±0.1 g/cm3
Package	bag, bottle, drum, or as you required
Storage	Store the container tightly closed in a dry & cool place. Do not expose to direct sunlight.
COA & MSDS	Available
Application	For research purpose

Usage

Goserelin is a parenterally administered, gonadotropin releasing hormone (GnRH) agonist which causes an inhibition of estrogen and androgen production and is used predominantly to treat prostate cancer.